BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
268.43
+1.04 (0.39%)
Mar 31, 2025, 9:55 AM EDT - Market open
BeiGene Employees
BeiGene had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$346,386
Profits / Employee
-$58,617
Market Cap
28.87B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ONC News
- 3 hours ago - BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer - Business Wire
- 27 days ago - China-Based Biotech BeiGene Scores FDA Approval For Tevimbra/Chemo Combo For Untreated Patients With Esophageal Cancer - Benzinga
- 27 days ago - TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with Chemotherapy - Business Wire
- 4 weeks ago - BeiGene: Q4 Results Impress With Positive Earnings Expected In 2025 - Seeking Alpha
- 4 weeks ago - BeiGene, Ltd. (ONC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates - Business Wire
- 4 weeks ago - BeiGene to Present at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27 - Business Wire